Kousei Ishigami

Closest collaborators

The 25 strongest of 61 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Kohei Nakata · 8 shared papers, 2022–2025 · strength 1.39
   • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
2. Naoki Ikenaga · 6 shared papers, 2022–2026 · strength 1.04
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
3. Nobuhiro Fujita · 5 shared papers, 2023–2025 · strength 0.97
   • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
4. Noboru Ideno · 5 shared papers, 2013–2025 · strength 0.73
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
   • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
5. Masafumi Nakamura · 4 shared papers, 2023–2025 · strength 0.72
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
   • Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
6. Yoshinao Oda · 4 shared papers, 2022–2025 · strength 0.70
   • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
   • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
   • Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
7. Toshiya Abe · 4 shared papers, 2022–2025 · strength 0.70
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
   • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
8. Nao Fujimori · 4 shared papers, 2022–2025 · strength 0.67
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
   • Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
9. Masatoshi Murakami · 3 shared papers, 2022–2025 · strength 0.52
   • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
   • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
   • Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
10. Shingo Baba · 3 shared papers, 2022–2026 · strength 0.50
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
    • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
    • Paper Prediction of pathological response to preoperative chemotherapy for pancreatic ductal adenocarcinoma using 2-[18F]-flu… DOI 10.1016/j.crad.2022.03.001↗
11. Yoshihiro Ogawa · 2 shared papers, 2022–2025 · strength 0.36
    • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
    • Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
12. So Nakamura · 2 shared papers, 2023 · strength 0.34
    • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
    • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
13. Kazuyoshi Nishihara · 2 shared papers, 2023 · strength 0.33
    • Paper Prognostic Impact of Preoperative Osteosarcopenia for Patients with Pancreatic Ductal Adenocarcinoma After Curative Res… DOI 10.1245/s10434-023-13936-z↗
    • Paper A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderlin… DOI 10.1245/s10434-022-12566-1↗
14. Masafumi Nakamura · 3 shared papers, 2013–2023 · strength 0.32
    • Paper Clinical Implications of FDG-PET in Pancreatic Ductal Adenocarcinoma Patients Treated with Neoadjuvant Therapy. DOI 10.1007/s11605-023-05591-2↗
    • Paper Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic canc… DOI 10.1007/s12672-021-00462-1↗
    • Paper Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with … DOI 10.1007/s00534-012-0541-7↗
15. Seiichiro Takao · 2 shared papers, 2021–2023 · strength 0.29
    • Paper Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy o… DOI 10.1016/j.ejrad.2023.110756↗
    • Paper Portal Vein Stenting for Jejunal Variceal Bleeding after Recurrence of Pancreatic Adenocarcinoma: A Case Report and Rev… DOI 10.22575/interventionalradiology.2020-0027↗
16. Shoko Noguchi · 1 shared paper, 2025 · strength 0.24
    • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
17. Takashi Matsumoto · 1 shared paper, 2025 · strength 0.24
    • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
18. Koji Shindo · 1 shared paper, 2025 · strength 0.24
    • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
19. Masafumi Nakamura · 1 shared paper, 2025 · strength 0.24
    • Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
20. Yusuke Watanabe · 1 shared paper, 2025 · strength 0.23
    • Paper Clinical efficacy of pancreas-preserving distal pancreatectomy for the treatment of pancreatic ductal adenocarcinoma. DOI 10.1016/j.surg.2024.108958↗
21. Isamu Makino · 1 shared paper, 2026 · strength 0.19
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
22. Atsushi Tomioka · 1 shared paper, 2026 · strength 0.19
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
23. Teiichi Sugiura · 1 shared paper, 2026 · strength 0.19
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
24. Shintaro Yagi · 1 shared paper, 2026 · strength 0.19
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗
25. Yoo‐Seok Yoon · 1 shared paper, 2026 · strength 0.19
    • Paper International multicenter validation of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography maxi… DOI 10.1016/j.surg.2026.110503↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.